INTERNATIONAL PATENT: SUZHOU RENBEN PHARMACEUTICAL CO. LTD, 苏州人本药业有限公司 FILES APPLICATION FOR "USE OF NADPH IN PREPARATION OF DRUG FOR TREATING MAJOR DEPRESSION, BIPOLAR DISORDER, POST-STROKE DEPRESSION OR NEUROINFLAMMATION"

GENEVA, April 21 -- SUZHOU RENBEN PHARMACEUTICAL CO. LTD (Room 307, Building B07, National University Science Park, Suzhou University, Industrial ParkSuzhou, Jiangsu 215123), 苏州人本药业有限公司 (中国江苏省苏州市工业园区苏州大学国家大学科技园B07栋307室) filed a patent application (PCT/CN2024/136058) for "USE OF NADPH IN PREPARATION OF DRUG FOR TREATING MAJOR DEPRESSION, BIPOLAR DISORDER, POST-STROKE DEPRESSION OR NEUROINFLAMMATION" on Dec 02, 2024. With publication no. WO/2025/077939, the details related to the patent application was...